Patterns and clinical relevance of antibody responses during adalimumab therapy

 
This item is provided by the institution :

Repository :
Annals of Gastroenterology
see the original item page
in the repository's web site and access all digital files if the item*
share



Report (EN)

2010 (EN)
Patterns and clinical relevance of antibody responses during adalimumab therapy (EN)

Katsanos, K.H.
Vagias, I.
Tsianos, V.
Tsianos, E.V.

All biologic therapies have the potential to induce immunogenicity. Homology reduces antigenicity, but ‘humanization' does not equate with homology and human antibodies may be also immunogenic. Despite of its proved efficacy in Crohn's disease patients, adalimumab carries the potential of molecule-specific toxicities which may be expressed with several types of antibody responses, and which are usually divided as allergic, autoimmunity and immunogenicity phenomena. (EN)

info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion

Ελληνική Γαστροεντερολογική Εταιρία (EL)
Hellenic Society of Gastroenterology (EN)

2010-07-09


Hellenic Society of Gastroenterology (EN)

1792-7463
1108-7471
Annals of Gastroenterology; Volume 23, No 3 (2010); 165 - 171 (EN)



*Institutions are responsible for keeping their URLs functional (digital file, item page in repository site)